Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Treatment of severe foot ischaemia by defibrination with ancrod: A randomized blind study

Treatment of severe foot ischaemia by defibrination with ancrod: A randomized blind study Forty-two patients, mean age 68 years, with severe leg ischaemia were randomly treated with placebo or by controlled defibrination with ancrod for 3 weeks. Plasma fibrinogen concentration was kept at about 20% of normal in the ancrod treated group. The two groups proved to be well matched regarding factors which could affect the degree of ischaemia. Objective measurements showed a significant rise in ankle and toe systolic blood pressure in the ancrod group lasting for 3 months. There was no rise in distal blood pressure in the control group. In the ancrod treated group the toe and ankle systolic pressures rose about 8 mmHg, but this was not accompanied by an improvement in the clinical course. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Scandinavian Journal of Clinical & Laboratory Investigation Taylor & Francis

Treatment of severe foot ischaemia by defibrination with ancrod: A randomized blind study

Treatment of severe foot ischaemia by defibrination with ancrod: A randomized blind study


Abstract

Forty-two patients, mean age 68 years, with severe leg ischaemia were randomly treated with placebo or by controlled defibrination with ancrod for 3 weeks. Plasma fibrinogen concentration was kept at about 20% of normal in the ancrod treated group. The two groups proved to be well matched regarding factors which could affect the degree of ischaemia. Objective measurements showed a significant rise in ankle and toe systolic blood pressure in the ancrod group lasting for 3 months. There was no rise in distal blood pressure in the control group. In the ancrod treated group the toe and ankle systolic pressures rose about 8 mmHg, but this was not accompanied by an improvement in the clinical course.

Loading next page...
 
/lp/taylor-francis/treatment-of-severe-foot-ischaemia-by-defibrination-with-ancrod-a-8NeXzOlxKi

References (13)

Publisher
Taylor & Francis
Copyright
© 1978 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted
ISSN
1502-7686
eISSN
0036-5513
DOI
10.3109/00365517809108447
Publisher site
See Article on Publisher Site

Abstract

Forty-two patients, mean age 68 years, with severe leg ischaemia were randomly treated with placebo or by controlled defibrination with ancrod for 3 weeks. Plasma fibrinogen concentration was kept at about 20% of normal in the ancrod treated group. The two groups proved to be well matched regarding factors which could affect the degree of ischaemia. Objective measurements showed a significant rise in ankle and toe systolic blood pressure in the ancrod group lasting for 3 months. There was no rise in distal blood pressure in the control group. In the ancrod treated group the toe and ankle systolic pressures rose about 8 mmHg, but this was not accompanied by an improvement in the clinical course.

Journal

Scandinavian Journal of Clinical & Laboratory InvestigationTaylor & Francis

Published: Sep 1, 1978

Keywords: ancrod; claudication; defibrination; ischaemia; leg ulcer; strain-gauge plethysmography

There are no references for this article.